FDA Warns For Risk of Mental Health Side Effects From from Asthma Drug
The U.S. Food and Drug Administration (FDA) has issued a warning about the potential risk of mental health side effects associated with certain asthma medications. The alert specifically focuses on the use of leukotriene inhibitors, a class of drugs commonly prescribed for asthma management.
According to the FDA, leukotriene inhibitors, which include popular drugs such as montelukast (brand name Singulair), have been linked to various mental health side effects. These may include changes in mood, behavior, or thinking, such as depression, anxiety, aggression, hallucinations, suicidal thoughts, and even completed suicides.
While the exact mechanism behind these side effects remains unclear, the FDA urges healthcare professionals, caregivers, and patients to be vigilant when taking or ...